SCHEMBL2720521

SCHEMBL2720521

CCN(Cc1cccs1)C(=O)/C=C/c1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 9/20 0.81
▸ L3MBTL1 Q9Y468 2/20 0.67
▸ NPC1 O15118 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ LTB4R Q15722 1/20 0.47
▸ LTB4R2 Q9NPC1 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2720524 1.00 TRPM8 (0.81) TRPM8L3MBTL1NPC1KDM4EALDH1A1
SCHEMBL2718603 0.90 TRPM8 (1.00) TRPM8L3MBTL1NPC1ALDH1A1
SCHEMBL2717965 0.90 TRPM8 (0.82) TRPM8L3MBTL1NPC1KDM4EALDH1A1
SCHEMBL2718605 0.90 TRPM8 (1.00) TRPM8L3MBTL1NPC1ALDH1A1
SCHEMBL2717967 0.90 TRPM8 (0.82) TRPM8L3MBTL1NPC1KDM4EALDH1A1
SCHEMBL17230208 0.90 TRPM8 (0.78) TRPM8L3MBTL1NPC1KDM4E
SCHEMBL10168528 0.89 TRPM8 (0.80) TRPM8L3MBTL1NPC1ALDH1A1MEN1
SCHEMBL2717146 0.89 TRPM8 (0.80) TRPM8L3MBTL1NPC1ALDH1A1MAPK1
SCHEMBL2717150 0.89 TRPM8 (0.80) TRPM8L3MBTL1NPC1ALDH1A1MAPK1
SCHEMBL2718501 0.87 TRPM8 (0.77) TRPM8KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132323-A1 COMPOSITIONS COMPRISING A SUNSCREEN ACTIVE AGENT DSM-FIRMENICH AG (CH) 2025-06-26 — — WO disclosed
EP-3470407-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2024-01-24 — — EP disclosed
US-11234450-B2 Preparations having a cooling effect SYMRISE AG (DE) 2022-02-01 — — US disclosed
US-11234450-B2 Preparations having a cooling effect SYMRISE AG (DE) 2022-02-01 — — US disclosed
EP-3478089-B1 PLATED YEAST FORMULATIONS FIRMENICH & CIE (CH) 2021-11-03 — — EP disclosed
US-11160894-B2 Perfume emanating device FIRMENICH SA (CH) 2021-11-02 — — US disclosed
US-11091734-B2 Plated yeast formulations FIRMENICH SA (CH) 2021-08-17 — — US disclosed
EP-2931225-B1 COOLING PREPARATIONS SYMRISE AG (DE) 2021-03-31 — — EP disclosed
US-10953007-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-03-23 — — US disclosed
US-10953007-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-03-23 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
EP-2931225-A1 PREPARATIONS Symrise AG (DE) 2015-10-21 — — EP disclosed
WO-2014090293-A1 PREPARATIONS SYMRISE AG (DE) 2014-06-19 — — WO disclosed
US-20130324557-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2013-12-05 — — US disclosed
EP-2635572-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11160894-B2 Perfume emanating device DPM1, SURF4, FAAH2 TRPM8 151/4885L3MBTL1 4084/4885NPC1 1230/4885
US-10953007-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885L3MBTL1 4024/4885NPC1 1050/4885
US-11234450-B2 Preparations having a cooling effect CRAT, CPT2, CPT1A TRPM8 60/4885L3MBTL1 4343/4885NPC1 1221/4885
US-20130324557-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885L3MBTL1 4024/4885NPC1 1050/4885
US-20150313820-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885L3MBTL1 4348/4885NPC1 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback